Jeon Kyeongman, Chung Man Pyo, Lee Kyung Soo, Chung Myung Jin, Han Joungho, Koh Won-Jung, Suh Gee Young, Kim Hojoong, Kwon O Jung
Division of Pulmonary and Critical Care Medicine, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, 50 Ilwon-dong, Kangnam-ku, Seoul 135-710, South Korea.
Respir Med. 2006 Mar;100(3):451-7. doi: 10.1016/j.rmed.2005.06.013. Epub 2005 Aug 3.
The purpose of this study was to investigate the prognostic factors at initial presentation and the causes of death in Korean patients with idiopathic pulmonary fibrosis (IPF), which might be different report wise, in comparison to the western countries. A retrospective review of 88 patients (mean 60.3 years, 69 male) was carried out and they were diagnosed as IPF positive. After diagnosis, the survival rate was 57% and 41% for third and fifth year, respectively (mean follow-up 39.1 months). Mortality was closely correlated with severe dyspnea at presentation (Hazard Ratio [HR], 2.6 per grade; p=0.015), lower initial forced vital capacity (HR, 1.7 per 10% predicted; p=0.004) and lower initial diffusing capacity of the lung (HR, 1.5 per 10% predicted; p=0.033). Treatment with specific drugs was ineffective against the survival when compared with symptomatic supportive care. Thirty-four patients (68%) died of worsened respiratory failure, seven (14%) died of infection and only one patient showed cardiovascular death. In conclusion, our study suggests that the severity of dyspnea and lung function tests at the time of diagnosis are the predictive factors for the survival of patients with IPF. In comparison to the reports from western countries, we observed that respiratory failure and pulmonary infection were more frequent causes of death, while cardiovascular death was rare in Korean patients with IPF.
本研究的目的是调查韩国特发性肺纤维化(IPF)患者初始就诊时的预后因素及死亡原因,与西方国家相比,这些因素可能因报告而异。对88例患者(平均年龄60.3岁,男性69例)进行了回顾性研究,他们被诊断为IPF阳性。诊断后,第三年和第五年的生存率分别为57%和41%(平均随访39.1个月)。死亡率与就诊时的严重呼吸困难密切相关(风险比[HR],每级2.6;p=0.015)、初始用力肺活量较低(HR,每降低预计值的10%为1.7;p=0.004)以及初始肺弥散能力较低(HR,每降低预计值的10%为1.5;p=0.033)。与对症支持治疗相比,使用特定药物治疗对生存率无效。34例患者(68%)死于呼吸衰竭加重,7例(14%)死于感染,只有1例患者死于心血管疾病。总之,我们的研究表明,诊断时的呼吸困难严重程度和肺功能测试是IPF患者生存的预测因素。与西方国家的报告相比,我们观察到呼吸衰竭和肺部感染是韩国IPF患者更常见的死亡原因,而心血管死亡则很少见。